Skip to content

Author

E. Mozzillo

We have 3 of 28 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Increasing incidence and clinical burden of paediatric type 1 diabetes in Italy: insights from a large administrative database.

BACKGROUND Paediatric type 1 diabetes (T1D) is a chronic disease that represents a global public health concern. Italian data describing epidemiology, comorbidity burden, and healthcare resource utilisation (HCRU) of paediatric T1D remain fragmented, mostly deriving from regional registries or limited cohorts. METHOD...

E. Mozzillo, C. Trimarchi, R. Buzzetti et al. · 0 citations
Open access Aug 2026

Salivary hormones and adipokines are associated with glycemic control and early renal and cardiometabolic markers in children and young adults with type 1 diabetes.

PURPOSE Type 1 diabetes (T1D) is recognized as a complex metabolic condition associated with hormonal dysregulation and early complications. This study aimed to evaluate salivary metabolic hormones and adipokines in children and young adults with T1D, and to assess their association with early markers of metabolic and...

A. Robino, G. Tornese, Luana Aldegheri et al. · 1 citation
Aug 2026

Continuous Glucose Monitoring and Automated Insulin Delivery in Infants with Type 1 Diabetes: Real-World Evidence to Support Future International Guidelines.

CGM is safe in very young children, with AID systems proving superior to traditional therapy, and real-world evidence supports incorporating AID consideration into future international guidelines from the time of pediatric diagnosis.

M. Marigliano, A. Scaramuzza, C. Arnaldi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.